Autoantibodies as potential biomarkers for breast cancer

Breast Cancer Research

Volumn 10, Issue 3, 2008, Pages

  Zhong, Li ^a,b   Ge, Kun ^a   Zu, Jin Chi ^a   Zhao, Long hua ^c   Shen, Wei Ke ^a   Wang, Jian Fei ^a   Zhang, Xiao Gang ^a   Gao, Xu ^d   Hu, Wanping ^e   Yen, Yun ^b   Kernstine, Kemp H ^b  

^a HEBEI UNIVERSITY   (China)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c China University of Geosciences Great Wall College   (China)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e Hematology and Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; BLOOD; BREAST TUMOR; CANCER STAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE LIBRARY; GENETICS; HUMAN; IMMUNOLOGY; METHODOLOGY; OPEN READING FRAME; POLYMERASE CHAIN REACTION; REPRODUCIBILITY;

ANTIGENS, NEOPLASM; AUTOANTIBODIES; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE LIBRARY; HUMANS; NEOPLASM STAGING; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 55749111068     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2091     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer Statistics, 2007. CA Cancer J Clin 2007, 57:43-66.
2. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007, 25:5287-5312. 10.1200/JCO.2007.14.2364, 17954709.
3. Naora H, Yang YQ, Montz FJ, Seidman JD, Kurman RJ, Roden RB. A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci USA 2001, 98:4060-4065. 31179, 11274429, 10.1073/pnas.071594398.
4. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Türeci O, Sahin U, Pfreundschuh M, Old LJ. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998, 76:652-658. 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P, 9610721.
5. Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jäger D, Jäger E, Knuth A, Chen YT, Old LJ. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 1999, 83:456-464. 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5, 10508479.
6. Hanash S. Disease proteomics. Nature 2003, 422:226-232. 10.1038/nature01514, 12634796.
7. Disis ML, Calenoff E, McLaughlin G, Murphy AE, Chen W, Groner B, Jeschke M, Lydon N, McGlynn E, Livingston RB, Moe R, Cheever MA. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 1994, 54:16-20.
8. Brass N, Rácz A, Bauer C, Heckel D, Sybrecht G, Meese E. Role of amplified genes in the production of autoantibodies. Blood 1999, 93:2158-2166.
9. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jäger D, Chen YT, Mackay A, O'Hare MJ, Old LJ. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun 2001, 1:4-20.
10. Chen YT, Scanlan MJ, Sahin U, Türeci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997, 94:1914-1918. 20017, 9050879, 10.1073/pnas.94.5.1914.
11. Jäger D, Stockert E, Güre AO, Scanlan MJ, Karbach J, Jäger E, Knuth A, Old LJ, Chen YT. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 2001, 61:2055-2061.
12. Gadducci A, Ferdeghini M, Buttitta F, Cosio S, Fanucchi A, Annicchiarico C, Gagetti O, Bevilacqua G, Genazzani AR. Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. Gynecol Oncol 1999, 72:76-81. 10.1006/gyno.1998.5101, 9889034.
13. Lechpammer M, Lukac J, Lechpammer S, Kovacević D, Loda M, Kusić Z. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy. Int J Colorectal Dis 2004, 19:114-120. 10.1007/s00384-003-0553-5, 14634775.
14. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006, 1:513-519.
15. Disis ML, Pupa SM, Gralow JR, Dittadi R, Menard S, Cheever MA. High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer. J Clin Oncol 1997, 15:3363-3367.
16. Wang RF, Rosenberg SA. Human tumor antigens recognized by T lymphocytes: implications for cancer therapy. J Leukoc Biol 1996, 60:296-309.
17. Sahin U, Türeci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995, 92:11810-11813. 40492, 8524854, 10.1073/pnas.92.25.11810.
18. Jäger E, Stockert E, Zidianakis Z, Chen YT, Karbach J, Jäger D, Arand M, Ritter G, Old LJ, Knuth A. Humoral immune responses of cancer patients against 'Cancer-Testis' antigen NY-ESO-1: correlation with clinical events. Int J Cancer 1999, 84:506-510. 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6, 10502728.
19. Zhong L, Peng X, Hidalgo GE, Doherty DE, Stromberg AJ, Hirschowitz EA. Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer. Proteomics 2004, 4:1216-1225. 10.1002/pmic.200200679, 15049001.
20. Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med. 2005, 172:1308-1314. 10.1164/rccm.200505-830OC, 16109979.
21. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402. 146917, 9254694, 10.1093/nar/25.17.3389.
22. Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, Sahin U, Barnes A, Robertson J. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol. 2007, 18:868-873. 17347129, 10.1093/annonc/mdm007.
23. Sugita Y, Wada H, Fujita S, Nakata T, Sato S, Noguchi Y, Jungbluth AA, Yamaguchi M, Chen YT, Stockert E, Gnjatic S, Williamson B, Scanlan MJ, Ono T, Sakita I, Yasui M, Miyoshi Y, Tamaki Y, Matsuura N, Noguchi S, Old LJ, Nakayama E, Monden M. NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors. Cancer Res 2004, 64:2199-2204. 10.1158/0008-5472.CAN-03-3070, 15026363.
24. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jäger D, Chen YT, Mackay A, O'Hare MJ, Old LJ. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun 2001, 1:4-21.
25. Qian F, Odunsi K, Blatt LM, Scanlan MJ, Mannan M, Shah N, Montgomery J, Haddad F, Taylor M. Tumor associated antigen recognition by autologous serum in patients with breast cancer. Int J Mol Med 2005, 15:137-144.
26. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jäger D, Chen YT, Mackay A, O'Hare MJ, Old LJ. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 2001, 61:2055-2061.
27. Volkmann M, Sinn HP, Gaugel D, Frey M, Hajjar Y, Ludwig J, Hänsel S, Bastert G, Wallwiener D, Fiehn W, Zentgraf H, Huober J. Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression. Oncology 2002, 63:297-305. 10.1159/000065472, 12381910.
28. Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Anticancer Res 1999, 19:3613-3618.
29. Abu-Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 2001, 60:433-440. 1753641, 11302861, 10.1136/ard.60.5.433.
30. Hanash S. Harnessing immunity for cancer marker discovery. Nat Biotechnol 2003, 21:37-38. 10.1038/nbt0103-37, 12511908.
31. Buccheri GF, Violante B, Sartoris AM, Ferrigno D, Curcio A, Vola F. Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma. Cancer 1986, 57:2389-2396. 10.1002/1097-0142(19860615)57:12<2389::AID-CNCR2820571225>3.0.CO;2-#, 3697937.
32. Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG, Hanash SM. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA 2001, 98:9824-9829. 55537, 11504947, 10.1073/pnas.171320598.
33. Davis CA, Benzer S. Generation of cDNA expression libraries enriched for in-frame sequences. Proc Natl Acad Sci USA 1997, 94:2128-2132. 20052, 9122159, 10.1073/pnas.94.6.2128.
34. Fernández Madrid F. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis. Cancer Lett 2005, 230:187-198. 10.1016/j.canlet.2004.12.017, 16297705.
35. Stevanovic S. Identification of tumor-associated T-cell epitopes for vaccine development. Nat Rev Cancer 2002, 2:514-520. 10.1038/nrc841, 12094237.
36. Sikic BI. New approaches in cancer treatment. Ann Oncol 1999, 10(Suppl 6):149-153. 10.1023/A:1008355801988, 10676567.
37. Rosell R, Green M, Gumerlock P. Advances in the treatment of non-small cell lung cancer:molecular markers take the stage. Semi Oncol 2001, 28:28-34. 11284622, 10.1016/S0093-7754(01)90301-X.
38. Rosell R, Sánchez JM, Tarón M, O'Brate A, Gutiérrez JL, Monzó M, Felip E, Sánchez JJ, Alberola V. Novel approaches in the treatment of non-small-cell lung cancer. Oncology (Williston Park) 2001, 15:52-60.
39. Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG, Kantoff PW, Rubin MA, Wei JT, Ghosh D, Chinnaiyan AM. Autoantibody signatures in prostate cancer. N Engl J Med 2005, 353:1224-1235. 10.1056/NEJMoa051931, 16177248.
40. Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 2006, 66:1181-1190. 10.1158/0008-5472.CAN-04-2962, 16424057.
41. Brankin B, Skaar TC, Brotzman M, Trock B, Clarke R. Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients. Cancer Epidemiol Biomarkers Prev 1998, 7:1109-1115.
42. Conroy SE, Sasieni PD, Fentiman I, Latchman DS. Autoantibodies to the 90 kDa heat shock protein and poor survival in breast cancer patients. Eur J Cancer 1998, 34:942-943.
43. Luo LY, Herrera I, Soosaipillai A, Diamandis EP. Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library. Br J Cancer 2002, 87:339-343. 10.1038/sj.bjc.6600439, 12177805.